Revolution Medicines Inc. (RVMD)
Market Closed
16 Oct, 08:00 PM
$
177. 96
-11.3
-5.9706%
$
40.57B Market Cap
- P/E Ratio
- Div Yield
2.97M Volume
-3.49 Eps
$ 189.26
Previous Close 
Want to track RVMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Revolution Medicines Inc. (RVMD) Statistics
Valuation metrics
Market Cap 40.57B
Enterprise value 40.17B
Trailing P/E (ttm) -21.42
Forward P/E -26.71
PEG ratio 0.38
Price/Sales (ttm) -
Price/Book (mrq) 15.36
Enterprise Value/Revenue -
Enterprise Value/EBITDA -23.76
Overview
Shares outstanding 197M
Float 179.86M
Shares short 15.41M
% Held by insiders 0.02%
% Held by institutions 0.96%
Average volume (10 days) 2.21M
Average volume (90 days) 1.84M
Price summary
52-Week low 49.05
52-Week high 224.31
Beta 1.01
50-Day moving average 202
200-Day moving average 150.46
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.41%
Return on equity -0.96%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -987.33M
EBITDA -1.17B
Net income to common (ttm) -1.13B
Diluted EPS (ttm) -8.38
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 2.03B
Total cash per share (mrq) 18.67
Total debt (mrq) 427.15M
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 11.38%
Book value per share (mrq) 12.36
Cash Flow
Cash flow statement -897.74M
Levered free cash flow (LFCF) -523.28M
2026 © Marketlog. All Rights Reserved.
